According to Insmed's latest financial reports the company's current EPS (TTM) is -4,63 โฌ. In 2022 the company made an earnings per share (EPS) of -3,43 โฌ a decrease over its 2021 EPS that were of -3,40 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -4,89 โฌ | 42.55% |
2022 | -3,43 โฌ | 0.78% |
2021 | -3,40 โฌ | 28.57% |
2020 | -2,65 โฌ | -0.99% |
2019 | -2,67 โฌ | -27.96% |
2018 | -3,71 โฌ | 47.55% |
2017 | -2,51 โฌ | 0.7% |
2016 | -2,50 โฌ | 39.9% |
2015 | -1,78 โฌ | 9.73% |
2014 | -1,63 โฌ | 17.09% |
2013 | -1,39 โฌ | 0.64% |
2012 | -1,38 โฌ | -46.42% |
2011 | -2,58 โฌ | 497.96% |
2010 | -0,43 โฌ | -105.1% |
2009 | 8,45 โฌ | -850.78% |
2008 | -1,13 โฌ | -24.71% |
2007 | -1,49 โฌ | -71.67% |
2006 | -5,27 โฌ | -28.57% |
2005 | -7,38 โฌ | 23.53% |
2004 | -5,98 โฌ | 134.48% |
2003 | -2,55 โฌ | -73.64% |
2002 | -9,67 โฌ | -2.65% |
2001 | -9,93 โฌ | -86.64% |
2000 | -74,38 โฌ |